发明名称 |
TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD |
摘要 |
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient. |
申请公布号 |
EP3028572(A1) |
申请公布日期 |
2016.06.08 |
申请号 |
EP20150178731 |
申请日期 |
2010.06.18 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES, LTD. |
发明人 |
TARCIC, NORA;BAR-ZOHAR, DAN;KOFLER, DINA |
分类号 |
A01N43/42;A61K31/136;A61K31/4704;A61K38/16;A61K45/06 |
主分类号 |
A01N43/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|